Prediction of response to adjuvant chemotherapy in premenopausal lymph node positive breast cancer patients with morphometry, DNA flow cytometry and Her-2/Neu oncoprotein expression. Preliminary results

P. J. Van Diest; J. P A Baak; P. Matze-Cok; S. S. Bacus

Prediction of response to adjuvant chemotherapy in premenopausal lymph node positive breast cancer patients with morphometry, DNA flow cytometry and Her-2/Neu oncoprotein expression. Preliminary results

P. J. Van Diest, J. P A Baak, P. Matze-Cok, S. S. Bacus

Research output: Contribution to journal › Article › peer-review

Abstract

The value of morphometry, DNA flow cytometry and HER-2/neu oncoprotein expression for prediction of response to adjuvant chemotherapy in premenopausal lymph node positive breast cancer patients was evaluated in a group of CMF treated patients and controls with long-term follow-up. In the treated group, the Morphometric Prognostic Index (cutpoint 1.1) was the best prognosticator (p

Original language	English (US)
Pages (from-to)	344-349
Number of pages	6
Journal	Pathology Research and Practice
Volume	188
Issue number	3
State	Published - 1992
Externally published	Yes

ASJC Scopus subject areas

Pathology and Forensic Medicine

Cite this

Prediction of response to adjuvant chemotherapy in premenopausal lymph node positive breast cancer patients with morphometry, DNA flow cytometry and Her-2/Neu oncoprotein expression. Preliminary results. / Van Diest, P. J.; Baak, J. P A; Matze-Cok, P.; Bacus, S. S.

In: Pathology Research and Practice, Vol. 188, No. 3, 1992, p. 344-349.

Research output: Contribution to journal › Article › peer-review

@article{98c818d7c9fa411a8991ff6a4f6e51ef,

title = "Prediction of response to adjuvant chemotherapy in premenopausal lymph node positive breast cancer patients with morphometry, DNA flow cytometry and Her-2/Neu oncoprotein expression. Preliminary results",

abstract = "The value of morphometry, DNA flow cytometry and HER-2/neu oncoprotein expression for prediction of response to adjuvant chemotherapy in premenopausal lymph node positive breast cancer patients was evaluated in a group of CMF treated patients and controls with long-term follow-up. In the treated group, the Morphometric Prognostic Index (cutpoint 1.1) was the best prognosticator (p ",

author = "{Van Diest}, {P. J.} and Baak, {J. P A} and P. Matze-Cok and Bacus, {S. S.}",

year = "1992",

language = "English (US)",

volume = "188",

pages = "344--349",

journal = "Pathology Research and Practice",

issn = "0344-0338",

publisher = "Urban und Fischer Verlag GmbH und Co. KG",

number = "3",

}

TY - JOUR

T1 - Prediction of response to adjuvant chemotherapy in premenopausal lymph node positive breast cancer patients with morphometry, DNA flow cytometry and Her-2/Neu oncoprotein expression. Preliminary results

AU - Van Diest, P. J.

AU - Baak, J. P A

AU - Matze-Cok, P.

AU - Bacus, S. S.

PY - 1992

Y1 - 1992

N2 - The value of morphometry, DNA flow cytometry and HER-2/neu oncoprotein expression for prediction of response to adjuvant chemotherapy in premenopausal lymph node positive breast cancer patients was evaluated in a group of CMF treated patients and controls with long-term follow-up. In the treated group, the Morphometric Prognostic Index (cutpoint 1.1) was the best prognosticator (p

AB - The value of morphometry, DNA flow cytometry and HER-2/neu oncoprotein expression for prediction of response to adjuvant chemotherapy in premenopausal lymph node positive breast cancer patients was evaluated in a group of CMF treated patients and controls with long-term follow-up. In the treated group, the Morphometric Prognostic Index (cutpoint 1.1) was the best prognosticator (p

UR - http://www.scopus.com/inward/record.url?scp=0026518882&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0026518882&partnerID=8YFLogxK

M3 - Article

C2 - 1378224

AN - SCOPUS:0026518882

VL - 188

SP - 344

EP - 349

JO - Pathology Research and Practice

JF - Pathology Research and Practice

SN - 0344-0338

IS - 3

ER -

Prediction of response to adjuvant chemotherapy in premenopausal lymph node positive breast cancer patients with morphometry, DNA flow cytometry and Her-2/Neu oncoprotein expression. Preliminary results

Abstract

ASJC Scopus subject areas

Other files and links

Fingerprint

Cite this